Value of post-operative reasses ...
The NICE trial was designed to evaluate the possible benefits of adding epidermal growth factor receptor targeted therapy to neoadjuvant chemotherap ...
Randomized, double-blind compar ...
Near-infrared (NIR) fluorescence imaging has the potential to improve sentinel lymph node (SLN) mapping in breast cancer. Indocyanine green (ICG) is ...
Interaction between goserelin a ...
Ovarian ablation improves survival in premenopausal early breast cancer, but the potential added value by luteinizing hormone-releasing hormone (LHR ...
G-protein-coupled estrogen rece ...
Recently, we have shown that the new G-protein- coupled estrogen receptor GPR30 plays an important role in the development of tamoxifen resistance i ...
A randomized, placebo-controlle ...
We hypothesized that exemestane (EXE) would reduce mammographic breast density and have unique effects on biomarkers of bone and lipid metabolism. ...
The association between vascula ...
Vascular endothelial growth factor (VEGF) is important in breast carcinogenesis. However, whether the effect of VEGF expression on survival varies w ...
Multiple biomarker expression o ...
Patients with locally advanced/inflammatory breast cancer (LABC/IBC) face a high likelyhood of recurrence and prognosis for relapsed, or de novo sta ...
Docetaxel metabolism is not alt ...
Docetaxel is primarily metabolized by CYP3A4 and susceptible to alterations in clearance by CYP3A4 inhibition and induction. Imatinib is a CYP3A4 in ...
Occult breast carcinoma in brea ...
Breast reduction is a common surgical procedure performed by plastic and oncoplastic breast surgeons. The authors report on the incidence and manage ...
Accuracy of unidimensional and ...
Pathological complete response (pCR) is an important predictor of long-term survival in patients with breast cancer receiving neoadjuvant chemothera ...
Evaluation of the association o ...
Trastuzumab (T) is effective in metastatic breast cancer (MBC) with HER2 overexpression and/or amplification, but resistance to T develops in a sign ...
Monthly versus 3-monthly gosere ...
This study compared the efficacy and safety of a 3-monthly 10.8-mg depot goserelin (ZoladexTM) injection with the current 3.6 mg monthly dose in pre ...
Characterizing the impact of 25 ...
The significant increase in the detection and treatment of ductal carcinoma in situ (DCIS) since the introduction of screening mammography has not b ...
Increased overall survival inde ...
Recent studies have reported the potential clinical utility for metastatic breast cancer (MBC) patients of continuing trastuzumab beyond progression ...
Health-related quality of life ...
To investigate whether the health-related quality of life (HRQOL) of patients switching from tamoxifen to anastrozole in a randomized trial is ident ...
Associations among baseline var ...
Provision of social support and rehabilitation for patients with physical, mental, and functional problems after cancer treatment is important for l ...
Epirubicin and paclitaxel with ...
An increased dose-intensity can be achieved by either higher dose of chemotherapy per cycle (dose-escalation) or by shortening the interval between ...
Letrozole plus GnRH analogue as ...
Patients with large ER positive tumors candidate to preoperative chemotherapy may also benefit from a concurrent endocrine intervention, but this is ...
Breast cancer screening in BRCA ...
Breast cancer screening is offered to BRCA1 and BRCA2 mutation carriers from the age of 25 years because of their increased risk of breast cancer. A ...
Mitotic activity and bone marro ...
The purpose of this article is to investigate the prognostic value of the mitotic activity index (MAI) and the presence of disseminated tumor cells ...
Comparison of the prognostic an ...
The Oncotype DX Recurrence Score (RS) is a validated genomic predictor of outcome and response to adjuvant chemotherapy in ER-positive breast canc ...
Prognosis in women with small ( ...
Knowledge is limited about prognostic significance of breast cancer subtypes among women with small invasive node-negative breast tumours. We explor ...
Strength training stops bone lo ...
Targeted exercise training could reduce risk factors for fracture and obesity-related diseases that increase from breast cancer treatment, but has n ...
Lobular and non-lobular breast ...
Invasive lobular carcinoma (ILC) accounts for 8–14% of all breast cancers and carries distinct prognostic and biologic implications. The goal of our ...
Mouse mammary tumor like virus ...
Mouse mammary tumor virus (MMTV) has been a long standing candidate as a potential cause of some human breast cancers. Forty years ago, electron mic ...